Literature DB >> 22654368

Treatment of lymphangioma of the face with intralesional bleomycin: case discussion and literature review.

Sertac Yetiser, Kutlay Karaman.   

Abstract

Surgical treatment of lymphangioma of the face is a difficult task to achieve due to close vicinity of the lesion to the facial nerve and possibility of scar tissue formation. Inefficient surgical removals generally will give rise to high recurrence rates because of infiltrative and diffuse extension of the lesion. However, complete cure has been described by non-surgical methods. A 5-year-old girl with extensive lymphangioma of the left cervicofacial area was treated with intralesional bleomycin injection under ultrasonographic guidance. Case discussion and related literature review was presented.

Entities:  

Keywords:  Bleomycin; Face; Lymphangioma; Treatment

Year:  2011        PMID: 22654368      PMCID: PMC3177523          DOI: 10.1007/s12663-011-0210-4

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  11 in total

1.  Treatment of lymphangioma in children: our experience of 128 cases.

Authors:  Tadaharu Okazaki; Saori Iwatani; Toshihiro Yanai; Hiroyuki Kobayashi; Yoshifumi Kato; Takashi Marusasa; Geoffrey J Lane; Atsuyuki Yamataka
Journal:  J Pediatr Surg       Date:  2007-02       Impact factor: 2.545

2.  Long-term results of intratumorous bleomycin-A5 injection for head and neck lymphangioma.

Authors:  P Q Zhong; F X Zhi; R Li; J L Xue; G Y Shu
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1998-08

3.  Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck.

Authors:  Neeraj N Mathur; Indu Rana; Rajendra Bothra; Rajiv Dhawan; Geeta Kathuria; Tapaswini Pradhan
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2005-01       Impact factor: 1.675

Review 4.  Nonsurgical therapies for lymphangiomas: a systematic review.

Authors:  Jason L Acevedo; Rahul K Shah; Scott E Brietzke
Journal:  Otolaryngol Head Neck Surg       Date:  2008-04       Impact factor: 3.497

5.  Injection of bleomycin as a primary therapy of cystic lymphangioma.

Authors:  A Okada; A Kubota; M Fukuzawa; K Imura; S Kamata
Journal:  J Pediatr Surg       Date:  1992-04       Impact factor: 2.545

6.  Bleomycin therapy for cystic hygroma.

Authors:  J Orford; A Barker; S Thonell; P King; J Murphy
Journal:  J Pediatr Surg       Date:  1995-09       Impact factor: 2.545

Review 7.  Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations.

Authors:  T Muir; M Kirsten; P Fourie; N Dippenaar; G O Ionescu
Journal:  Pediatr Surg Int       Date:  2004-01-22       Impact factor: 1.827

8.  OK-432 therapy in 64 patients with lymphangioma.

Authors:  S Ogita; T Tsuto; K Nakamura; E Deguchi; N Iwai
Journal:  J Pediatr Surg       Date:  1994-06       Impact factor: 2.545

9.  Sclerotherapy for lymphangioma in children.

Authors:  I Sanlialp; I Karnak; F C Tanyel; M E Senocak; N Büyükpamukçu
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2003-07       Impact factor: 1.675

10.  Treatment of cystic hygroma and lymphangioma with the use of bleomycin fat emulsion.

Authors:  N Tanigawa; T Shimomatsuya; K Takahashi; Y Inomata; K Tanaka; K Satomura; Y Hikasa; M Hashida; S Muranishi; H Sezaki
Journal:  Cancer       Date:  1987-08-15       Impact factor: 6.860

View more
  2 in total

1.  Acute neonatal presentation of a lymphatic malformation.

Authors:  Chee Yan Tang; M Wijnen; S J Sambeeck van; F J J Halbertsma
Journal:  BMJ Case Rep       Date:  2013-08-01

2.  Long term outcomes of transcutaneous non-image guided bleomycin sclerotherapy in orbital/adnexal lymphatic malformations: a protocol-based management in 69 eyes.

Authors:  Tarjani Vivek Dave; Bejjanki Kavya Madhuri; Srujana Laghmisetty; Devjyoti Tripathy; Swathi Kaliki; Suryasnata Rath; Samir Mohapatra; Akruti Desai; Anasua Ganguly Kapoor
Journal:  Eye (Lond)       Date:  2021-04-20       Impact factor: 3.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.